CervoMed (CRVO) Competitors

Candel Therapeutics (NASDAQ:CADL) and CervoMed (NASDAQ:CRVO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, community ranking, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Do insiders and institutionals have more ownership in CADL or CRVO?

13.9% of Candel Therapeutics shares are held by institutional investors. Comparatively, 25.1% of CervoMed shares are held by institutional investors. 16.6% of Candel Therapeutics shares are held by company insiders. Comparatively, 35.4% of CervoMed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more risk & volatility, CADL or CRVO?

Candel Therapeutics has a beta of -0.87, indicating that its share price is 187% less volatile than the S&P 500. Comparatively, CervoMed has a beta of -0.73, indicating that its share price is 173% less volatile than the S&P 500.

Do analysts rate CADL or CRVO?

Candel Therapeutics currently has a consensus price target of $21.00, indicating a potential upside of 258.97%. CervoMed has a consensus price target of $27.63, indicating a potential upside of 257.84%. Given Candel Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Candel Therapeutics is more favorable than CervoMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Candel Therapeutics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
CervoMed	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

Is CADL or CRVO more profitable?

Candel Therapeutics has a net margin of 0.00% compared to CervoMed's net margin of -118.68%. CervoMed's return on equity of -44.11% beat Candel Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Candel Therapeutics	N/A	-629.29%	-173.39%
CervoMed	-118.68%	-44.11%	-39.81%

Does the media prefer CADL or CRVO?

In the previous week, Candel Therapeutics had 1 more articles in the media than CervoMed. MarketBeat recorded 4 mentions for Candel Therapeutics and 3 mentions for CervoMed. Candel Therapeutics' average media sentiment score of 1.22 beat CervoMed's score of 0.90 indicating that Candel Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Candel Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CervoMed	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer CADL or CRVO?

CervoMed received 8 more outperform votes than Candel Therapeutics when rated by MarketBeat users. Likewise, 75.76% of users gave CervoMed an outperform vote while only 65.38% of users gave Candel Therapeutics an outperform vote.

Company	Underperform	Outperform
Candel Therapeutics	Outperform Votes 17 65.38%	Underperform Votes 9 34.62%
CervoMed	Outperform Votes 25 75.76%	Underperform Votes 8 24.24%

Which has preferable earnings and valuation, CADL or CRVO?

CervoMed has higher revenue and earnings than Candel Therapeutics. Candel Therapeutics is trading at a lower price-to-earnings ratio than CervoMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Candel Therapeutics	$120K	2,442.52	-$37.94M	-$1.34	-4.37
CervoMed	$7.14M	9.41	-$2.17M	-$2.18	-3.54

Summary

CervoMed beats Candel Therapeutics on 11 of the 19 factors compared between the two stocks.